首页> 外国专利> The constituent for remedying or prevention the dementia disease and the anti- dementia glaze null which designates that as prescription

The constituent for remedying or prevention the dementia disease and the anti- dementia glaze null which designates that as prescription

机译:用于补救或预防痴呆症疾病和抗痴呆釉的成分无效,将其指定为处方

摘要

PURPOSE: To obtain antidemential agent having strong learning ability and dementia-preventing and treating effects by containing one or more kinds of metabolism of 12 lipoxygenase from docosahexaenoic acid or its salt, ester and amide as an active ingredient. ;CONSTITUTION: A composition containing one or more kinds of 12-lipoxygenase metabolism from docosahexaenoic acid (DHA) or its salt, ester amide, especially 10-hydroxy-13,14-epoxydocosatetraenoic acid, 12-hydroxy-13.14-epoxydocosatetraenoic acid, 10.13.14-trihydroxydocosatetraenoic acid and 12.13.14-trihydroxydocosatetraenoic acid or these derivatives as active ingredients and useful for treatment or prevention of dementia disease. Further, the composition is prepared as necessary together with other preparation by 2 pharmacologically permissible diluent or carrier so that the composition is administered in an amount of 0.01-1000mg/day to provide antidemential agent.;COPYRIGHT: (C)1993,JPO&Japio
机译:用途:通过含有二十二碳六烯酸或其盐,酯和酰胺为活性成分的12种脂氧合酶的一种或多种代谢,来获得学习能力强,预防和治疗痴呆的抗痴呆剂。组成:一种组合物,含有一种或多种由二十二碳六烯酸(DHA)或其盐,酯酰胺代谢的12-脂氧合酶,特别是10-羟基-13,14-环氧二十二碳四烯酸,12-羟基-13.14-环氧二十二碳四烯酸,10.13 .14-三羟基二十二碳四烯酸和12.13.14-三羟基二十二碳四烯酸或这些衍生物作为有效成分,可用于治疗或预防痴呆症。此外,该组合物根据需要与其他制剂一起通过2种药理上允许的稀释剂或载体制备,从而以0.01-1000mg /天的量施用该组合物以提供抗痴呆剂。;版权:(C)1993,JPO&Japio

著录项

  • 公开/公告号JP3213760B2

    专利类型

  • 公开/公告日2001-10-02

    原文格式PDF

  • 申请/专利权人 マルハ株式会社;

    申请/专利号JP19910307089

  • 发明设计人 西川 正純;木村 省二;

    申请日1991-10-24

  • 分类号A61K31/202;A61K31/336;A61P25/28;

  • 国家 JP

  • 入库时间 2022-08-22 01:35:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号